Anti-tumor immune response in early stage non small cell lung cancer (NSCLC): implications for adjuvant therapy.
about
Anti-tumor immune response in early stage non small cell lung cancer (NSCLC): implications for adjuvant therapy.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Anti-tumor immune response in ...... ications for adjuvant therapy.
@en
type
label
Anti-tumor immune response in ...... ications for adjuvant therapy.
@en
prefLabel
Anti-tumor immune response in ...... ications for adjuvant therapy.
@en
P2860
P1476
Anti-tumor immune response in ...... ications for adjuvant therapy.
@en
P2093
Charles A Butts
P2860
P304
P356
10.3978/J.ISSN.2218-6751.2013.10.09
P577
2013-10-01T00:00:00Z